Press Releases

Investor Alerts

Mar 5, 2020

Satsuma Pharmaceuticals Appoints Rob Janosky as Chief Commercial Officer
Feb 18, 2020

Satsuma Pharmaceuticals to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Jan 28, 2020

Satsuma Pharmaceuticals Announces Publication of STS101 Phase 1 Clinical Trial Results in HEADACHE: The Journal of Head and Face Pain
Nov 26, 2019

Satsuma Pharmaceuticals to Present at the 2nd Annual Evercore ISI HealthCONx Conference
Nov 12, 2019

Satsuma Pharmaceuticals Reports Third Quarter 2019 Financial and Business Results

Completed upsized initial public offering of $90.8 million in gross proceeds

Show per page